Just, two diabetic retinopathy underthesion image auxiliary diagnostic software products approved!

Guide: Is there a new product coming out of diabetic retinopathy? Just now, the State Drug Administration approved the products of the diabetic retinopathy eye bottom image auxiliary diagnostic software from Shenzhen Silicon-based Intelligent Technology Co., Ltd. and Shanghai Eagle Medical Technology Co., Ltd.
it is well known that diabeticretinopathy (DR) is one of the most common and serious complications of diabetes and the main cause of low vision and blindness in adults.
the disease in prevention and early intervention, eye-to-eye examination or under-eye color photography can help confirm the diagnosis, but patients need to go to the hospital regularly, many patients lack awareness of the disease, often delay diagnosis and treatment, and eventually blind.
said that just approved two products, Shenzhen Silicon-based Intelligent Technology Co. , Ltd. products by the installation of U disk, functional modules include: diabetic retinopathy auxiliary diagnosis cloud, doctor diagnosis client and system management end.
is suitable for the analysis of the color undereye images of both eyes in adult diabetic patients, and provides medical practitioners with the supporting diagnostic recommendations for visible stage II and above diabetic retinopathy and further medical examination.
is understood that Shenzhen Silicon-based Intelligent Technology Co., Ltd. is a company dedicated to medical active implantation and medical artificial intelligence research and development and industrialization, the company is headquartered in Shenzhen.
, the company has offices in Los Angeles, Beijing and Guangzhou.
product layout includes implantable retinal electrostimulators, uncalibrated continuous glucose monitoring (CGM), sugar net screening, and screening for stomach cancer.
and Shanghai Eagle Medical Technology Co., Ltd. (i.e., "Airdoc") products include client software and server-side software, product server-side deployment in Alibaba Cloud, client deployed in the client computer, server-side and the client through the Internet encrypted data interaction.
is suitable for the analysis of the image of the double-dispersive color underthesion of the eyes of adult diabetic patients, and provides the medical practitionerwith with the recommendation of auxiliary diagnosis on whether to detect moderate non-proliferativity (including) or above diabetic retinopathy and further medical examination.
Airdoc was founded in 2015 and is a joint team of core technology products from top companies such as Microsoft, Google, Yahoo, Sina, Johnson and Johnson, Pfizer and others.
in November 2015, Airdoc received an investment in the Angel Wheel of the Hill Angel Society.
follow-up to The Search Dog, Fosun, Ping An, CITIC multi-round financing.
Airdoc has been involved in areas such as the eye, skin, brain, nerves, cardiovascular, pathology, large imaging, etc.
its products in medical institutions, mirror chain, medical examination institutions have been throughout the country, every day for tens of thousands of users to provide health risk screening services.
both products use the self-designed network structure based on convolutional neural network, and train and verify the algorithm model based on the under-eye image data of the classification label.
by obtaining the patient's under-eye color photo taken by the under-eye camera, using the above-mentioned deep learning algorithm to calculate and analyze the image, to obtain the auxiliary diagnosis of diabetic retinopathy recommendations, to provide the corresponding qualifications for clinicians as a reference.
it is worth mentioning that there is no similar products approved for listing in China.
in the past two years, in order to speed up the approval process of AI medical products, the State Drug Administration opened a green channel.
Since April 2019, five sugar net and coronary products, such as Koya Medical, Eagle Medical, Numerical Technology and Silicon-based Intelligence, have entered the "Green Channel for Innovative Medical Devices".
into 2020, China's AI product approval is ushered in a major breakthrough.
January 15, 2020, the coronary blood flow reserve score calculation software productdevelopdeveloped by Coya Medical has been approved by the Center for Review of Machines, becoming the first three types of devices in China to be approved for the application of artificial intelligence technology.
February 7, 2020, The Artificial Intelligence Electrocardiogram (AI-ECGPlatform), an autonomous artificial intelligence "AI-ECGPlatform" developed by Shenzhen Kaivol Electronics Co., Ltd., a wholly-owned subsidiary of The AI Division of Lepu (Beijing) Medical Devices Co., Ltd., has also become the only artificial intelligence electrocardiogram product that has been approved by NMPA, FDA approved and CE certified at the same time.
plus just approved two products, it can be said that after years of development, China's AI medical industry commercialization process is accelerating, AI medical for their own name may not be far away.
.